Jihane Saade
Gerontology · North Bergen, NJNPI 1306591516
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,781 of the $9,145 with a category attached, or 74.2%. It is spread thinly across 60 manufacturers, the largest accounting for just 21.4%. Among gerontology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 365 payments — averaging $25.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- Amgen$980
- AbbVie$556
- AstraZeneca$553
- BD$425
- Daiichi Sankyo Inc.$375
- plus $4K from 54 others
What the payments were for
- Consulting fees$6507%
- Food & beverage$6,78174%
- Education$4345%
- Other$1,28014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,145 in reported general payments places this provider in the 95th percentile of 374 gerontology providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RevlimidLenalidomide | 17 | $322,338 |
| CabometyxCabozantinib S-Malate | 11 | $277,957 |
| EliquisApixaban | 51 | $44,856 |
| XareltoRivaroxaban | 32 | $35,665 |
| Imatinib Mesylate | 17 | $8,373 |
| Anastrozole | 180 | $3,845 |
| Exemestane | 19 | $2,438 |
| Letrozole | 43 | $1,227 |
| Tamoxifen Citrate | 26 | $795 |
| Prochlorperazine Maleate | 44 | $562 |
| Hydroxyurea | 23 | $506 |
| Dexamethasone | 35 | $487 |
| Ondansetron OdtOndansetron | 51 | $424 |
| Warfarin Sodium | 39 | $291 |
| Pantoprazole Sodium | 21 | $280 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bristol Myers SquibbRevlimid | $17 | $322,33817 claims |
| PfizerEliquis | $52 | $44,85651 claims |
| Johnson & JohnsonXarelto | $329 | $35,66532 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 374 gerontology providers in New Jersey.
Other gerontology in North Bergen
- Jose BadiaNorth Bergen$5K
- Dana JonesTeaneck$150K
- Jennifer FoxFlemington$76K
- Susan HermidaBrick$33K
- Joseph RudolphCamden$8K
- Jennifer LernerNew Brunswick$7K
- Josephine MachadoNew Brunswick$7K
- Remya JamesNew Brunswick$7K
- Anna HaEnglewood$7K
- Myoung ParkBayonne$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.